Mereo Biopharma Group Plc (MREO) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mereo Biopharma Group Plc  (NASDAQ: MREO)


Mereo Biopharma Group Plc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Mereo Biopharma Group Plc's ROI in the second quarter of 2026?
Mereo Biopharma Group Plc recorded a cumulative net loss of $-28 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -69.98%.

Within the Healthcare sector 357 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3352 to 3778.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 35.98 % 41.02 % 88.11 % 114.68 % -50.62 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 29 36 43 52 62
Return On Investment (TTM) -69.98 % -73.9 % -75.72 % -69.09 % -167.81 %
MREO's Overall Ranking # 3778 # 3352 # 3498 # 3641 # 3227
Seq. Investment Change TTM -16.9 % -12.63 % -8.08 % 103.77 % -13.83 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -28 -36 -42 -42 -50

MREO Company Profile >> Back to MREO Roi Comparisons >> See Annual MREO Return On Investment



Return On Investment MREO's Ranking
Within: No.
Industry # 146
Sector # 358
Overall # 3778

Return On Investment Statistics
High Average Low
10.75 %
-91.42 %
-363.49 %
(Dec 31 2021)   (Dec 31 2020)







Financial Statements
Mereo Biopharma Group Plc's II. Quarter Investments $ 29 Millions MREO's Balance sheet
Mereo Biopharma Group Plc's II. Quarter Income $ -7 Millions Quarterly MREO's Income Statement
MREO's Income by Division See MREO's Income by Division


MREO Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 42 63 57 53 113
Y / Y Investment Growth -33.46 % 9.64 % 7.01 % -53 % 52.49 %
Net Income in Millions 42 43 29 -42 18
Y / Y Net Income Growth -3.18 % 46.79 % - - -
Annual Return On Investment 100.63 % 69.16 % 51.65 % -79.2 % 15.44 %


Annual Roi Comment
Despite deterioration in net income, company improved ROI to in the fiscal year 2025, company improved ROI to 100.63 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MREO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MREO's Competitors
Subscribers only: Roi for Mereo Biopharma Group Plc's Suppliers
Subscribers only: Return On Investment for MREO's Customers

Other Ratios
MREO's Roa MREO's Inventory Turnover Ratio MREO's Growth Rates MREO's Dividend Statistics
MREO's Profitability Ratios MREO's Asset Turnover Ratio MREO's Dividend Growth
MREO's Roe MREO's Valuation Ratios MREO's Financial Strength Ratios MREO's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-30T13:41:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.